Key Documents
Rona Giffard
- Professor, Anesthesia
- Member, Bio-X
Contact Information
- Clinical Offices
Anesthesia 300 Pasteur Dr H2512 MC 5637 Stanford, CA 94304 Telephone Work (650) 725-5875 Fax (650) 725-8052
- Academic Offices
Personal Information Email Rona.Giffard@stanford.edu
Administrative Appointments
- Vice-Chair for Research, Dept. of Anesthesia , (1999– present )
Honors and Awards
- NIH Clinical Investigator Award, NIH (1990-1995)
- Young Investigator Award, Foundation for Anesthesia Education and Research (1991-1992)
- Ellen Weaver Award, Association for Women in Science, Northern California Chapters (1997)
- Frontiers in Anesthesia Research Award, International Anesthesia Research Society (1998-2003)
- AHA/Bugher Award, American Heart Association (2000-2004)
Professional Education
- Ph.D., StanfordUniversity Structural Biology
- M.D., Stanford University Medicine
Postdoctoral Advisees
Graduate & Fellowship Program Affiliations
Web Site Links
Research Interests
Brain injury from stroke, head trauma, and chronic neurologic degenerative diseases, is a major cause of morbidity and mortality. We are particularly interested in the cellular consequences of brain injury. To study this problem we work with primary cultures of neurons and astrocytes from mice in addition to employing rodent models of stroke. Current work focuses on: 1) the role of astrocytes in brain injury; 2) the interaction of neurons and glia during injury; 3) protection using heat shock protein and anti-apoptotic protein overexpression 4) changes in mitochondrial function and signaling in injury; 5) the interaction of oxidative stress and inflammation in stroke; 6) computational modeling of cell death.
We use gene transfer techniques to express genes of interest in brain cells and intact brain and analyze ways in which these genes can provide protection. We use fluorescent probes for pH, intracellular calcium, ROS, mitochondrial membrane potential, glutathione, as well as morphologically evaluate outcome, and quantitate injury. We also use transgenic mice to analyze the effects of overexpression or loss of expression of specific genes on outcome from stroke. Mitochondria are central to both energy metabolism and the regulation of cell death. We study changes in mitochondria with stress. We are also interested in the interaction of oxidative stress and inflammation in stroke.
A new area for us is computational modeling of cell death and the effects of heat shock proteins. We are working on an ODE control model.
Publications
- Anesth Analg. 2009; (1): 280-7
- Neurobiol Dis. 2009; (2): 301-12
- J Cereb Blood Flow Metab. 2009; (2): 365-74
- J Cereb Blood Flow Metab. 2008; (5): 1009-16
- Anesthesiology. 2008; (2): 339-48
- Neurosci Lett. 2007; (2): 201-4
- J Neurochem. 2007; (4): 1383-94
- J Neurosci. 2007; (16): 4253-60
- FEBS Lett. 2006; (20): 4865-71
- Cell Stress Chaperones. 2006; (2): 180-6
- J Thorac Cardiovasc Surg. 2006; (3): 659-65
- J Cereb Blood Flow Metab. 2006; (8): 1076-88
- J Cereb Blood Flow Metab. 2006; (7): 937-50
- Neurobiol Aging. 2006; (4): 562-9
- Stroke. 2006; (4): 1087-93
- Pediatr Res. 2005; (4): 475-80
- Free Radic Biol Med. 2005; (8): 1112-8
- Glia. 2005; (4): 299-306
- Neurosci Lett. 2005; (3): 229-33
- Ann N Y Acad Sci. 2005; 74-83
- Cell Calcium. 2004 Sep-Oct; (3-4): 303-11
- Neurochem Int. 2004 Jul-Aug; (2-3): 371-9
- J Bioenerg Biomembr. 2004; (4): 313-5
- Neurol Res. 2004; (6): 632-43
- J Exp Biol. 2004; (Pt 18): 3213-20
- Neuropharmacology. 2004; (1): 136-45
- J Neurosurg Anesthesiol. 2004; (1): 53-61
- Exp Neurol. 2004; (1): 122-30
- Neuroreport. 2004; (3): 499-502
- Anesthesiology. 2003; (5): 1039-41
- J Cereb Blood Flow Metab. 2003; (10): 1113-6
- Neurol Res. 2003; (7): 697-700
- J Cereb Blood Flow Metab. 2003; (3): 275-9
- Ann N Y Acad Sci. 2003; 54-68; discussion 79-81
- Eur J Neurosci. 2003; (11): 2935-45
- Curr Opin Anaesthesiol. 2002; (5): 495-500
- J Cereb Blood Flow Metab. 2002; (1): 21-8
- J Neurosci. 2002; (10): 3921-8
- Free Radic Biol Med. 2002; (4): 544-51
- Ann Neurol. 2002; (2): 160-7
- Neurol Res. 2002; (8): 796-800
- Mol Cells. 2002; (2): 288-94
- J Neurochem. 2002; (4): 914-23
- Neurosci Lett. 2001; (1): 5-8
- Exp Neurol. 2001; (2): 416-24
- Exp Neurol. 2001; (1): 129-39
- J Cereb Blood Flow Metab. 2001; (11): 1303-9
- Yonsei Med J. 2001; (5): 471-9
- Reg Anesth Pain Med. 2000 Jan-Feb; (1): 22-5
- Br J Neurosurg. 2000; (5): 407-14
- J Neurosci. 2000; (3): 1001-8
- Br J Neurosurg. 2000; (4): 305-12
- Anesthesiology. 1999; (4): 1036-46
- Mol Med Today. 1999; (12): 525-31
- Neurosci Lett. 1999; (3): 193-7
- Neuroreport. 1998; (5): 875-9
- Brain Res. 1998; (1-2): 10-6
- Eur J Neurosci. 1998; (4): 1252-60
- Anesth Analg. 1998; (5): 1206-8
- Neuroscience. 1998; (3): 915-25
- Brain Res. 1997; (1-2): 151-6
- Cancer Res. 1997; (19): 4200-4
- Neurosci Lett. 1997; (1): 9-12
- J Biol Chem. 1997; (17): 11276-82
- Neurol Res. 1996; (1): 64-72
- Neuroreport. 1996; (2): 429-32
- J Neurosci. 1995; (6): 4545-55
- Eur J Neurosci. 1995; (9): 1906-13
- Brain Res. 1995; (1-2): 188-98
- J Cereb Blood Flow Metab. 1995; (5): 865-76
- J Neurochem. 1995; (2): 652-9
- J Neurochem. 1994; (4): 1398-406
- Science. 1993; (5113): 1516-8
- J Cereb Blood Flow Metab. 1993; (5): 803-10
- Neuron. 1992; (5): 967-73
- Stroke. 1992; (12): 1817-21
- Adv Exp Med Biol. 1990; 501-4
- Brain Res. 1990; (2): 339-42
- Brain Res. 1990; (1): 138-41
- J Neurosurg Anesthesiol. 1989; (4): 364-7
- J Cell Biol. 1984; (5): 1796-803
- J Muscle Res Cell Motil. 1983; (1): 115-31